Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Marmur

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Thrombosis and Haemostasis|July 1, 1997
Tissue factor in the pathogenesis of atherosclerosisM B Taubman, J T Fallon, A D Schecter, et al.
Journal of the American College of Cardiology|September 14, 1999
Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary interventionA Kini, J D Marmur, S Kini, et al.
Journal of the American College of Cardiology|November 15, 1994
Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplastyJ D Marmur, P A Merlini, S K Sharma, et al.
The American Journal of Cardiology|April 13, 2000
Balloon optimization versus stent study (BOSS): provisional stenting and early recoil after balloon angioplastyG Dangas, J A Ambrose, D Rehmann, et al.
Circulation|March 21, 2001
Testing platelet activation with a shear-dependent platelet function test versus aggregation-based tests: relevance for monitoring long-term glycoprotein IIb/IIIa inhibitionJ I Osende, V Fuster, E I Lev, et al.
Plastic and Reconstructive Surgery|November 12, 1998
Locally administered vascular endothelial growth factor cDNA increases survival of ischemic experimental skin flapsP J Taub, J D Marmur, W X Zhang, et al.
Circulation|September 15, 1996
Identification of active tissue factor in human coronary atheromaJ D Marmur, S V Thiruvikraman, B S Fyfe, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 26, 1998
Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximabG Dangas, J J Badimon, B S Coller, et al.
The American Journal of Cardiology|July 15, 1997
Risk factors for the development of slow flow during rotational coronary atherectomyS K Sharma, G Dangas, R Mehran, et al.
The American Journal of Cardiology|May 10, 2000
Antithrombotic effects of abciximabR Hayes, J H Chesebro, V Fuster, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Thrombosis and Haemostasis|July 1, 1997
Tissue factor in the pathogenesis of atherosclerosisM B Taubman, J T Fallon, A D Schecter, et al.
Journal of the American College of Cardiology|September 14, 1999
Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary interventionA Kini, J D Marmur, S Kini, et al.
Journal of the American College of Cardiology|November 15, 1994
Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplastyJ D Marmur, P A Merlini, S K Sharma, et al.
The American Journal of Cardiology|April 13, 2000
Balloon optimization versus stent study (BOSS): provisional stenting and early recoil after balloon angioplastyG Dangas, J A Ambrose, D Rehmann, et al.
Circulation|March 21, 2001
Testing platelet activation with a shear-dependent platelet function test versus aggregation-based tests: relevance for monitoring long-term glycoprotein IIb/IIIa inhibitionJ I Osende, V Fuster, E I Lev, et al.
Plastic and Reconstructive Surgery|November 12, 1998
Locally administered vascular endothelial growth factor cDNA increases survival of ischemic experimental skin flapsP J Taub, J D Marmur, W X Zhang, et al.
Circulation|September 15, 1996
Identification of active tissue factor in human coronary atheromaJ D Marmur, S V Thiruvikraman, B S Fyfe, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 26, 1998
Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximabG Dangas, J J Badimon, B S Coller, et al.
The American Journal of Cardiology|July 15, 1997
Risk factors for the development of slow flow during rotational coronary atherectomyS K Sharma, G Dangas, R Mehran, et al.
The American Journal of Cardiology|May 10, 2000
Antithrombotic effects of abciximabR Hayes, J H Chesebro, V Fuster, et al.
Pageof 4